MedPath

The Diagnostic Yield and Safety of Transbronchial Cryobiopsy in Different Freezing Time in the Diffuse Parenchymal Lung Diseases

Not Applicable
Conditions
Diagnostic Yield
Transbronchial Cryobiopsy
Freezing Time
Safety
Interventions
Procedure: Transbronchial Cryobiopsy
Registration Number
NCT03927235
Lead Sponsor
Guangzhou Institute of Respiratory Disease
Brief Summary

Transbronchial cryobiopsy in different freezing time is performed in patients with undefined diffuse parenchymal lung diseases, and assess the diagnostic yield and safety.

Detailed Description

Transbronchial cryobiopsy in different freezing time is performed in patients with undefined diffuse parenchymal lung diseases, and assess the diagnostic yield and safety. This is a prospective randomized control trial.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  1. The patients are admitted in the institution as DPLD, while undefined after thorough history collection, laboratory examination and radiological data.
  2. Transbronchial cryobiopsy(TBCB) is indicated by clinicians for definitive diagnosis and patients are content with the examination with agreement signed.
  3. Blood gas analysis, routine blood test, ECG examination, coagulation function, immunological examination, chest HRCT, and liver/kidney function test have been completed.
Exclusion Criteria
  1. The radiological data indicates non-DPLD
  2. The clinical examinations mentioned above are not completed.
  3. The patient cannot endure or does not agree the procedure.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
the freezing time of 5sTransbronchial CryobiopsyTransbronchial cryobiopsy in the freezing time of 5s
the freezing time of 3sTransbronchial CryobiopsyTransbronchial cryobiopsy in the freezing time of 3s
the freezing time of 6sTransbronchial CryobiopsyTransbronchial cryobiopsy in the freezing time of 6s
the freezing time of 4sTransbronchial CryobiopsyTransbronchial cryobiopsy in the freezing time of 4s
Primary Outcome Measures
NameTimeMethod
Diagnotic yieldtwo weeks

Percentage of definitive pathological diagnosis by transbronchial cryobiopsy, the alteration of original diagnosis after transbronchial cryobiopsy

Secondary Outcome Measures
NameTimeMethod
Complication rateone week

Incidence of bleeding, pneumothorax (during the procedure and within 7 days after the intervention) and exacerbations of DPLD related to the transbronchial cryobiopsy

Trial Locations

Locations (1)

the First Affiliated Hospital of Guangzhou Medical University

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath